Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/ PD-L1/PD-L2 alterations

Marthe Minderman, Avital Amir, Willem Kraan, Esther J. M. Schilder-Tol, Monique E. C. M. Oud, Cornelis G. Scheepstra, Arnold L. Noorduyn, Philip M. Kluin, Marie José Kersten, Marcel Spaargaren, Steven T. Pals

Blood (2021) 138 (13): 1194–1197.

https://doi.org/10.1182/blood.2021011366

Published: 2021

Includes: Supplemental data

Journal Articles

Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma

Blood (2021) 137 (11): 1491–1502.

https://doi.org/10.1182/blood.2020007245

Published: 2021

Includes: Supplemental data

Journal Articles

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Blood (2021) 137 (10): 1353–1364.

https://doi.org/10.1182/blood.2020006464

Published: 2021

Includes: Supplemental data

Journal Articles

EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

Alexandre S. Cristino, Jamie Nourse, Rachael A. West, Muhammed Bilal Sabdia, Soi C. Law, Jay Gunawardana, Frank Vari, Sally Mujaj, Gayathri Thillaiyampalam, Cameron Snell, Madeline Gough, Colm Keane, Maher K. Gandhi

Blood (2019) 134 (25): 2261–2270.

https://doi.org/10.1182/blood.2019000889

Published: 2019

Includes: Supplemental data

Journal Articles

Ruxolitinib Reverses Checkpoint Inhibition By Downregulating PD-L1 and PD-L2 Expression on Both Tumor and Stromal Cells in Multiple Myeloma

Haiming Chen, MD PhD, Mingjie Li, BS, Eric Sanchez, BA, Nicole Ng, BS, Erin Yu, BS, Sean Bujarski, BA, Zhengyi Yin, Tara Hekmati, Dylan Field, Jasper Wang, Isabella Nassir, Janna Yu, Justin Huang, David Daniely, Cathy S. Wang, BS, Ning Xu, PhD, James R. Berenson, MD

Blood (2019) 134 (Supplement_1): 4402.

https://doi.org/10.1182/blood-2019-130888

Published: 2019

Journal Articles

Tissue-Resident PSGL1 lo CD4 + T Cells Interact with B Cells Via PD-1 and PD-L2 in Gvhd Target Tissues to Augment Autoimmune-like Chronic Gvhd

Xiaohui Kong, PhD, Deye Zeng, MD, Xiwei Wu, PhD, Shijie Yang, PhD, Bixin Wang, Qingxiao Song, MD PhD, Yongping Zhu, Martha Salas, Hanjun Qin, Ubaydah Nasri, Ryotaro Nakamura, MD, Paul J Martin, MD, Aimin Huang, Defu Zeng, MD PhD

Blood (2019) 134 (Supplement_1): 5607.

https://doi.org/10.1182/blood-2019-126315

Published: 2019

Journal Articles

Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma

Linda von Hoff, Eva Kärgel, Vedran Franke, Erik McShane, Kathrin W. Schulz-Beiss, Giannino Patone, Nikolai Schleussner, Marina Kolesnichenko, Norbert Hübner, Oliver Daumke, Matthias Selbach, Altuna Akalin, Stephan Mathas, Claus Scheidereit

Blood (2019) 133 (13): 1489–1494.

https://doi.org/10.1182/blood-2018-08-871293

Published: 2019

Includes: Supplemental data

Journal Articles

Characterization of Soluble Immune Checkpoint Protein PD-1, PD-L1 and PD-L2 Levels in Different Types of Lymphoid Malignancies

Julie Bondgaard Mortensen, MS, Vladimirova Yoanna, B.Sc, Ida Monrad Hansen, B.Sc., Mette Bjerre, M.Sc. PhD, Francesco d'Amore, MD

Blood (2018) 132 (Supplement 1): 5306.

https://doi.org/10.1182/blood-2018-99-114509

Published: 2018

Journal Articles

The JAK Inhibitor Blocks PD-L1, PD-L2 and CD44 Expression in Multiple Myeloma (MM) and Sensitizes MM Cells to Lenalidomide and Steroids

Haiming Chen, MD PhD, Mingjie Li, BS, Eric Sanchez, BA, Camilia M. Soof, BS, Sean Bujarski, BA, Nicole Ng, Jasmin Cao, BS, Tara Hekmati, BS, Edward J Tanenbaum, BS, Brian Zahab, Cathy S. Wang, BS, George Y Tang, PhD, Ning Xu, PhD, James R Berenson, MD

Blood (2018) 132 (Supplement 1): 1910.

https://doi.org/10.1182/blood-2018-99-119099

Published: 2018

Journal Articles

Peripheral Blood As a Substitute for Bone Marrow for Assessing the Immune Profile in AML

Robin Lesley, PhD, Karl Beutner, Abraham A Anderson, Dan Fitzpatrick, Robert Loberg, Bhakti Mehta, Cedric E. Dos Santos

Blood (2017) 130 (Supplement 1): 3924.

https://doi.org/10.1182/blood.V130.Suppl_1.3924.3924

Published: 2017

Journal Articles

High Amount of PD1+TIM3+ T Helper Cells May Predict Poor Outcome in Adult Acute Lymphoblastic Leukemia

Helena Hohtari, MD, Oscar Brück, Sami Blom, MSc, Riku Turkki, MSc, Antonio Ribeiro, BSc, Marjatta Sinisalo, MD PhD, Panu Kovanen, MD PhD, Olli Kallioniemi, MD PhD, Teijo Pellinen, PhD, Kimmo Porkka, MD PhD, Satu Mustjoki, MDPhD

Blood (2017) 130 (Supplement 1): 3985.

https://doi.org/10.1182/blood.V130.Suppl_1.3985.3985

Published: 2017

Journal Articles

Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma

Min Young Lee, MD PhD, Chan-jeoung Park, MD, Young-Uk Cho, Eunkyoung You, Seongsoo Jang, MD, Jung-Hee Lee, MD PhD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4400.

https://doi.org/10.1182/blood.V130.Suppl_1.4400.4400

Published: 2017

Journal Articles

Eosinophils Upregulate PD-L1 and PD-L2 Expression to Enhance the Immunosuppressive Microenvironment in Multiple Myeloma

James Driscoll, MD PhD, Irim Aslam, Ehsan Malek, MD

Blood (2017) 130 (Supplement 1): 4417.

https://doi.org/10.1182/blood.V130.Suppl_1.4417.4417

Published: 2017

Journal Articles

T Cell Versus T Cell; A Study of the Immune Checkpoint Landscape in Cutaneous T Cell Lymphoma

Duncan Murray, FRCPath, MRCP, MA, BMBS, Suzy A Eldershaw, BSc. (Hons.), PhD, Hayden Pearce, BSc. (Hons.), PhD, Nathaniel Davies, MSci, PhD, Jack McMurray, BSc, Julia J. Scarisbrick, MD FRCP, MBBS †, Paul Moss, MBBS, PhD FRCP

Blood (2017) 130 (Supplement 1): 2754.

https://doi.org/10.1182/blood.V130.Suppl_1.2754.2754

Published: 2017

Journal Articles

Comparison of Genetic Profiling of Primary Central Nervous System (CNS) Lymphoma before and after Extra-CNS Relapse

Kosuke Toyoda, MD, Junko Nomoto, MD PhD, Yasuji Miyakita, MD, Yoshitaka Narita, MD PhD, Akiko Miyagi Maeshima, MD PhD, Nobuhiko Yamauchi, MD, Suguru Fukuhara, MD, Wataru Munakata, MD PhD, Dai Maruyama, MD PhD, Kensei Tobinai, MD PhD, Yukio Kobayashi, MD PhD

Blood (2017) 130 (Supplement 1): 5135.

https://doi.org/10.1182/blood.V130.Suppl_1.5135.5135

Published: 2017

Journal Articles

Checkpoint Expression By Acute Myeloid Leukemia (AML) and the Immune Microenvironment Suppresses Adaptive Immunity

Blood (2017) 130 (Supplement 1): 185.

https://doi.org/10.1182/blood.V130.Suppl_1.185.185

Published: 2017

Journal Articles

Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma

W. Robert Liu, Margaret A. Shipp

Blood (2017) 130 (21): 2265–2270.

https://doi.org/10.1182/blood-2017-06-781989

Published: 2017

Journal Articles

Chromosome 9p24.1/ PD-L1 / PD-L2 Alterations and PD-L1 Expression and Treatment Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Nivolumab (PD-1 Blockade)

Blood (2016) 128 (22): 2923.

https://doi.org/10.1182/blood.V128.22.2923.2923

Published: 2016

Journal Articles

Altered Expression of Immune Checkpoint Molecules Including Programmed Cell Death-1 (PD-1) and Its Ligands PD-L1/PD-L2 in Waldenstrom's Macroglobulinemia

Shahrzad Jalali, PhD, Tammy Price-Troska, BS, Anne J. Novak, PhD, Stephen M Ansell, MD, PhD

Blood (2016) 128 (22): 1772.

https://doi.org/10.1182/blood.V128.22.1772.1772

Published: 2016

Journal Articles

Non-Canonical Autophagy during APL Therapy

Jing Jin, PhD, Magali Humbert, PhD, Mario P. Tschan, PhD

Blood (2016) 128 (22): 1621.

https://doi.org/10.1182/blood.V128.22.1621.1621

Published: 2016

NARROW

Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/ PD-L1/PD-L2 alterations

Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

Ruxolitinib Reverses Checkpoint Inhibition By Downregulating PD-L1 and PD-L2 Expression on Both Tumor and Stromal Cells in Multiple Myeloma

Tissue-Resident PSGL1 lo CD4 + T Cells Interact with B Cells Via PD-1 and PD-L2 in Gvhd Target Tissues to Augment Autoimmune-like Chronic Gvhd

Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma

Characterization of Soluble Immune Checkpoint Protein PD-1, PD-L1 and PD-L2 Levels in Different Types of Lymphoid Malignancies

The JAK Inhibitor Blocks PD-L1, PD-L2 and CD44 Expression in Multiple Myeloma (MM) and Sensitizes MM Cells to Lenalidomide and Steroids

Peripheral Blood As a Substitute for Bone Marrow for Assessing the Immune Profile in AML

High Amount of PD1+TIM3+ T Helper Cells May Predict Poor Outcome in Adult Acute Lymphoblastic Leukemia

Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma

Eosinophils Upregulate PD-L1 and PD-L2 Expression to Enhance the Immunosuppressive Microenvironment in Multiple Myeloma

T Cell Versus T Cell; A Study of the Immune Checkpoint Landscape in Cutaneous T Cell Lymphoma

Comparison of Genetic Profiling of Primary Central Nervous System (CNS) Lymphoma before and after Extra-CNS Relapse

Checkpoint Expression By Acute Myeloid Leukemia (AML) and the Immune Microenvironment Suppresses Adaptive Immunity

Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma

Chromosome 9p24.1/ PD-L1 / PD-L2 Alterations and PD-L1 Expression and Treatment Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Nivolumab (PD-1 Blockade)

Altered Expression of Immune Checkpoint Molecules Including Programmed Cell Death-1 (PD-1) and Its Ligands PD-L1/PD-L2 in Waldenstrom's Macroglobulinemia

Non-Canonical Autophagy during APL Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only